1 year return (CAGR)
90.00%
Entero Therapeutics, Inc. Exchange (NASDAQ, USD)
ENTO
-
-0.15 (-5.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-77.93%
5 year return (CAGR)
-89.58%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
9.58M
Price/Sales
-
Ent value
52.87M
Price/Book
0.11
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-13.37%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-82.08%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 3.00 |
| Daily high | 3.15 |
| Daily low | 2.82 |
| Daily Volume | 93K |
| 1y analyst estimate | 36.00 |
| Beta | 1.15 |
| EPS (TTM) | -9.47 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ENTO | S&P500 | |
| Current price drop from All-time high | -100.00% | -0.21% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 29 Jan 2026 | 9 Mar 2009 |
| Avg drop from high | -79.04% | -10.68% |
| Avg time to new high | 1169 days | 12 days |
| Max time to new high | 2337 days | 1805 days |
News
No items found